secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001683168-24-001099
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals receives Nasdaq delisting notice over equity shortfall; will request hearing
--------------------------------------------------------------------------------

- Nasdaq notified CNSP on Feb 14, 2024, that it failed to meet minimum $2.5M stockholders' equity requirement after extension expired.
- Company intends to request a hearing before a Nasdaq Hearings Panel, which will automatically stay suspension or delisting pending the hearing.
- Panel may grant an extension not to exceed August 12, 2024, but compliance is not assured.
- Previous extension was granted until Feb 13, 2024; company still non-compliant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824001099/0001683168-24-001099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824001099/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-001099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer